Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Control Bionics Limited

Market Cap 37.49M 26.28M 22.92M 21.22M 19.87M 37.26M 2.48B 252M 97.58M 1.22B 98.66M 96.55M 4.24B P/E 2024
-1.4x
P/E 2025 -1.3x
Enterprise Value 37.25M 26.12M 22.77M 21.09M 19.74M 37.03M 2.46B 250M 96.97M 1.21B 98.04M 95.93M 4.21B EV / Sales 2024
1.92x
EV / Sales 2025 1.4x
Free-Float
47.41%
Yield 2024 *
-
Yield 2025 -
1 day+3.41%
1 week+4.60%
Current month+62.50%
1 month+49.18%
3 months+65.45%
6 months+28.17%
Current year+49.18%
1 week 0.08
Extreme 0.085
0.09
1 month 0.06
Extreme 0.055
0.1
Current year 0.05
Extreme 0.05
0.1
1 year 0.03
Extreme 0.026
0.1
3 years 0.03
Extreme 0.026
0.1
5 years 0.03
Extreme 0.026
0.74
10 years 0.03
Extreme 0.026
1.24
Manager TitleAgeSince
Chief Executive Officer - 18/01/2023
Director of Finance/CFO - 12/05/2024
Chief Tech/Sci/R&D Officer - 31/12/2013
Director TitleAgeSince
Chairman - 30/11/2025
Chairman 66 18/11/2025
Director/Board Member - 18/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+3.41%+4.60%+203.33%-3.19% 25.47M
-1.89%-7.55%+1.67%-40.08% 15.48B
-2.00%-5.85%+25.78%+48.91% 1.57B
+0.19%+0.84%-28.35%+19.81% 1.12B
+4.11%-2.98%-51.75%-84.40% 932M
+5.56%+6.44%-16.36%-51.84% 678M
+0.58%-1.38%-40.36%-58.31% 554M
+3.24%-4.53%+37.29%-54.10% 444M
-1.26%-1.88%-53.89%-62.94% 382M
-3.12%+4.11%-26.69%-25.41% 341M
Average +0.98%-1.31%+5.07%-31.15% 2.15B
Weighted average by Cap. -0.80%-4.64%-2.55%-33.66%

Financials

2024 2025
Net sales 5.35M 3.75M 3.27M 3.03M 2.84M 5.32M 354M 35.94M 13.93M 174M 14.08M 13.78M 605M 6.14M 4.31M 3.76M 3.48M 3.26M 6.11M 407M 41.27M 16M 200M 16.17M 15.83M 695M
Net income -5.91M -4.15M -3.62M -3.35M -3.13M -5.88M -391M -39.72M -15.39M -193M -15.56M -15.23M -669M -6.11M -4.28M -3.73M -3.46M -3.24M -6.07M -404M -41.03M -15.9M -199M -16.08M -15.73M -691M
Net Debt -96.95K -67.97K -59.26K -54.89K -51.38K -96.36K -6.41M -651K -252K -3.16M -255K -250K -10.96M -237K -166K -145K -134K -126K -236K -15.7M -1.59M -618K -7.73M -624K -611K -26.83M
Logo Control Bionics Limited
Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.
Employees
-
Date Price Change Volume
19/06/26 0.0910 $ +3.41% 226,580
18/06/26 0.0880 $ -5.38% 543,447
17/06/26 0.0930 $ +3.33% 423,797
16/06/26 0.0900 $ -1.10% 120,485
15/06/26 0.0910 $ +1.11% 747,940

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!